发明名称 |
Crystalline PI3 kinase inhibitors |
摘要 |
<p>There is provided inter alia 6-(2-((4-arnino-3-(3-hydroxyphenyl)-1 H-pyrazolo[3,4-d]pyrirnidin-1-yl) methyl)-3-(2-chlorobenzyl)-4-oxo-3,4-dihydroquinazolin-5-yl)-N,N-bis(2-methoxyethyl)hex-5- ynamide in the form of a solid crystalline hydrate and in solid crystalline anhydrous form. There are also provided dry powder pharmaceutical compositions for inhalation containing such solid crystalline forms.</p> |
申请公布号 |
AU2013234081(A1) |
申请公布日期 |
2014.08.21 |
申请号 |
AU20130234081 |
申请日期 |
2013.03.13 |
申请人 |
RESPIVERT LIMITED |
发明人 |
BROECKX, RUDY LAURENT MARIA;FILLIERS, WALTER FERDINAND MARIA;NIESTE, PATRICK HUBERT J.;COPMANS, ALEX HERMAN;VANHOUTTE, FILIP MARCEL C.;LEYS, CARINA |
分类号 |
C07D487/04 |
主分类号 |
C07D487/04 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|